Effects of Gamigukihwandong-hwan on Renal Function, Oxidative Stress and Polyol Pathway in Diabetic Nephropathy Rats

Streptozotocin으로 유발된 흰쥐의 당뇨병성 신증에서 가미구기환동환(加味枸杞還童丸)이 Oxidative Stress 및 Polyol Pathway에 미치는 영향

  • Jeong, Hyung-Cheol (Department of Internal Medicine, College of Korean Medicine, Dongguk University) ;
  • Jeong, Ji-Cheon (Department of Internal Medicine, College of Korean Medicine, Dongguk University)
  • 정형철 (동국대학교 한의과대학 내과학교실) ;
  • 정지천 (동국대학교 한의과대학 내과학교실)
  • Published : 2007.06.25

Abstract

Diabetes is a disease in which the body does not produce or properly use insulin. Etiological studies of diabetes and its complications showed that oxidative stress might play a major role. Therefore, many efforts have been tried to regulate free oxygen radicals for treating diabetes and its complications. Gamigukihwandong-hwan has been known to be effective for the treatment of diabetes. The present study was carried out to investigate the effect of Gamigukihwandong-hwan on renal function, peroxynitrite (ONOO$^-$) scavenging activity and polyol pathway in streptozotocin-induced diabetic rats. The crushed Gamigukihwandong-hwan was extracted 3 times, each time with 3 volumes of methyl alcohol at 60$^{\circ}C$ for 24 h. The extract was filtered and evaporated under a reduced pressure using a rotary evaporator to yield 74.95 g. Gamigukihwandong-hwan extract was oral-administered 100 mg per 1 kg of body weight for 20 days to the diabetic rats induced by streptozotocin (60 mg/kg). The effects of Gamigukihwandong-hwan extract on the streptozotocin-induced diabetic rats were observed by measuring the serum level of glucose, insulin, lipid components, creatinine and BUN, and also the kidney levels of superoxide anion radical (${\cdot}O_2^-$), nitric oxide (NO) and ONOO$^-$, and also the enzyme activities involved in polyol pathway. The Effects of Gamigukihwandong-hwan on the streptozotocin-induced diabetic rats with regards to body weight, blood glucose and insulin levels, creatinine and BUN levels, total cholesterol and triglyceride levels, and HDL-cholesterol levels were all shown to be good enough to cure and prevent the diabetes and its complications. Gamigukihwandong-hwan inhibited the generation of ${\cdot}O_2^-$, NO and ONOO$^-$ in the kidney of streptozotocin-induced diabetic rats. Renal aldose reductase and sorbitol dehydrogenase activities were increased in the streptozotocin-induced diabetic rats, whereas the ones in the Gamigukihwandong-hwan administered group among the streptozotocin-induced diabetic rats were reversed toward the natural activities. Gamigukihwandong-hwan might inhibit the development of diabetic nephropathy by scavenging reactive oxygen and nitrogen species, thereby by reducing oxidative stresses and also by regulating the activities of polyol pathway enzymes, all of which could help to recover the function of kidney.

Keywords

References

  1. Baynes, J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40: 405-412, 1991 https://doi.org/10.2337/diabetes.40.4.405
  2. Maureen, I.H. and Michaela, M. Screening for NIDDM. Diabetes Care. 17: 440-444, 1994 https://doi.org/10.2337/diacare.17.5.440
  3. Hammers, H.D., Martin, S., Fedesrlin, K., Geisen, K. and Brownlee, M. Aminoguanidine treatment inhibit the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA. 88: 11555-11558, 1991
  4. 김응진 외. 당뇨병학. 서울, 고려의학, pp 15-43, 32-33, 149-169, 391-468, 475-487, 609-616, 1998
  5. Viberti, G.C., Walker, J.D. Diabetic nephropathy : etiology and prevention. Diabetes/Metab Rev. 4: 147-159, 1988 https://doi.org/10.1002/dmr.5610040205
  6. 대한신장학회 등록위원회. 우리나라 신대체요법의 현황. 대한신장학회지 21(suppl 2):S189-203, 2002
  7. Yagoob, M., McClelland, P., Patrick, A.W., Stevenson, A., Mason, H., White, M.C., Bell, G.M. Evidence of oxidant injury and tubular damage in early diabetic nephropathy. Q. J. Med. 87: 601-607, 1994
  8. Noh, H., Ha, H., Yu, M.R., Kang, S.W., Choi, K.H., Han, D.S., Lee, H.Y. High glucose increase inducible NO production in cultured rat mesangial cells. Nephron. 90: 78-85, 2002 https://doi.org/10.1159/000046318
  9. Bennai, F., Morsing, P., Paliege, A., Ketteler, M., Mayer, B., Tapp, R., Bachmann, S. Normalizing the expression of nitric oxide synthase by low dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats. J Am Soc Nephrol. 10(Suppl 77):S104-115, 1999
  10. Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A. and Freeman, B.A. Apparent hydroxyl radical production by peroxynitrite : implications for endothelial injury from nitric oxideand superoxide. Proc Natl Acad Sci USA. 87: 1620-1624, 1990
  11. Pugliese, G., Tilton, G.T. and Williamson, J.R. Glucose-induced metabolic imbalance in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev. 7: 35-59, 1991 https://doi.org/10.1002/dmr.5610070106
  12. Stevens, M.J., Dananberg, J., Feldman, E.L., Lattimer, S.A., Kamijo, M., Thomas, T.P., Shindo, H., Sima, A.A. and Greene, D.A. The linked roles of nitric oxide, aldose reductase and Na-K-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest. 94: 853-859, 1994 https://doi.org/10.1172/JCI117406
  13. 方藥中. 實用中醫內科學. 上海, 上海科學技術出版社, p 477, 1986
  14. 余永譜. 中醫治療內分泌代謝疾病. 浙江, 浙江科學技術出版社, p 239, 243, 1992
  15. 강석봉. 消渴의 傳變證과 당뇨병의 만성합병증에 대한 비교 고찰. 대한한의학회지 19(2):137-152, 1998
  16. 김형준, 윤철호, 정지천. 珍糖元의 고혈당 조절 작용 및 기전에 관한 연구. 대한한방내과학회지 25(2):277-287, 2004
  17. 이철웅, 정지천, 신현철. 고혈당 흰쥐에서 蠐螬의 혈당 조절과 항산화작용에 관한 연구. 대한한의학회지 27(1):91-103, 2006
  18. 朱 橚. 普濟方. 서울, 翰成社, p 3339, 1995
  19. 何紹奇, 宋乃光 編著. 中老年保健養生方. 北京, 學苑出版社, pp 208-209, 219-220, 2002
  20. 王毅, 靳長金 朱君波 編著. 益壽效方 120. 北京, 中國醫藥科技出版社, pp 31-32, 95, 1989
  21. 廬祥之 編著. 益壽延年二百方. 北京, 中國中醫藥出版社, p 150, 1991
  22. Thomson, R.H. Colorimetric glucose oxidase method for blood glucose. Clin Chem Acta. 13: 133-135, 1966 https://doi.org/10.1016/0009-8981(66)90281-6
  23. Miller, B.F. and Dubos, R. Studies on the presence of creatinine in human blood. J. Bio. Chem., 121: 447, 1937
  24. Tietz, N.W. Fundamentals of clinical chemistry. Philadelphia, W. B. Saunders Company, pp 991-998, 1976
  25. Levinson, S.S. Use of an enzymatic method for cholesterol, designed for continuous flow instrumention, with discrete bichromatic and centrifugation analysis. Clin. Chem. 23: 2335-2337, 1977
  26. Flether, M.J. A colorimetric method for estimation serum triglyceride. Clin. Chem. 22: 393, 1968
  27. Cathcart, R., Schwiers, E., Ames, B.N. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein fluorescent assay. Anal Biochem. 134: 111-116, 1983 https://doi.org/10.1016/0003-2697(83)90270-1
  28. Nagata, N., Momose, K., Ishida, Y. Inhibitory effects of catecholamines and anti- oxidants on the fluorescence reaction of 4,5-diaminofluorescein, DAF-2, a novel indicator of nitric oxide. J Biochem Tokyo. 125: 658-661, 1999 https://doi.org/10.1093/oxfordjournals.jbchem.a022333
  29. Kooy, N.W., Royall, J.A., Ischiropoulos, H., Beckman, J.S. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic Res Commun. 16: 149-156, 1994
  30. Yamaoka, T., Nishimura, C., Yamashita, K., Itakura, M., Yamada, T., Fujimoto, J. and Kokai, Y. Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Diabetologia. 38: 255-261, 1995 https://doi.org/10.1007/BF00400627
  31. Hollmann, S. In Hoppe-Seyler Thiefelder : Handbuch der physiol. und path.-chem. Vol. VIa. Berlin-Heidelberg-New York, Analyse Springer. p 704, 1964
  32. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J. Protein measurement with folin phenol reagent. J Biol Chem. 193: 265-275, 1951
  33. Viberti, G.C., Wiseman, M.J. The kidney in diabetes : Significance of the early abnormalities. Clin Endocrinol Metab. 15: 753-760, 1986 https://doi.org/10.1016/S0300-595X(86)80073-1
  34. Wardle, E.n. Cell biology and the function changes of diabetic nephropathy. Nephrol Dial Transplant. 7: 889-895, 1992 https://doi.org/10.1093/ndt/7.9.889
  35. Paller, M.S., Neumann, T.V. Reactive oxygen species and rat renal epithelial cells during hypoxia and reoxygeneration. Kidney Int. 40: 1041-1049, 1991 https://doi.org/10.1038/ki.1991.312
  36. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-development diabetes mellitus. N Engl J Med. 329: 977-986, 1993 https://doi.org/10.1056/NEJM199309303291401
  37. 黃春林 外. 心腎疾病臨證證治. 廣東, 廣東人民出版社, p 316, 2000
  38. 陳以平. 腎病的辨證與辨病治療. 北京, 人民衛生出版社, pp 143-161, 2003
  39. 李尙仁. 本草學. 서울, 醫藥社, pp 71, 74, 118-119, 207, 1981
  40. 吳儀洛. 本草從新. 上海, 上海科學技術出版社, pp 22-23, 67, 180, 1982
  41. 王其飛 外. 中醫長壽學. 遼寧, 遼寧科學技術出版社, pp 53-54, 327-329, 331-334, 1989
  42. 王浴生. 中藥藥理與應用. 北京, 人民衛生出版社, pp 741-743, 998-1000, 1983